Balo Andrew K's Form 4 filing
Dexcom Inc (DXCM) · filed Aug 4, 2021
- Accession no.
- 0001093557-21-000195
- Filed
- Aug 4, 2021
- Trade date
- Aug 3, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $1.42M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Balo Andrew KCIK 0001323190 | Officer (*) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 | Common Stock | SSaleDisposed | −683 | $512.19F2 | −$349,825.77 | 12,726 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −200 | $512.83F4 | −$102,566 | 12,526 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −300 | $514.18F5 | −$154,254 | 12,226 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −300 | $515.33F6 | −$154,599 | 11,926 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −200 | $516.72F7 | −$103,344 | 11,726 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −200 | $518.06F8 | −$103,612 | 11,526 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −525 | $519.24F9 | −$272,601 | 11,001 | Indirect | |
| Aug 3, 2021 | Common Stock | SSaleDisposed | −349 | $519.92F10 | −$181,452.08 | 10,652 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $511.45 to $512.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $512.46 to $513.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $513.59 to $514.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $515.00 to $515.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $516.425 to $517.020. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $517.600 to $518.515. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $518.60 to $519.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $519.64 to $520.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
*EVP Regulatory Strategy Clinical Affairs and Strategic Partnership Development